BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
4.740
+0.060 (1.28%)
Nov 18, 2025, 3:18 PM EST - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $8.52 million as of November 18, 2025. Its market cap has increased by 31.65% in one year.
Market Cap
8.52M
Enterprise Value
5.59M
1-Year Change
31.65%
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $8.52M, a decrease of -79.78%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 8.41M | 67.31% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 194.10B |
| BHP Group | 135.06B |
| Rio Tinto Group | 121.15B |
| Southern Copper | 103.21B |
| Newmont | 94.47B |
| Agnico Eagle Mines | 83.40B |
| The Sherwin-Williams Company | 80.50B |
| CRH plc | 72.64B |